Adherence to medications by patients after acute coronary syndromes

Annals of Pharmacotherapy

Volumn 39, Issue 11, 2005, Pages 1792-1797

  Sud, Anchal ^a   Kline Rogers, Eva M ^b   Eagle, Kim A ^b   Fang, Jianming ^b   Armstrong, David F ^b   Rangarajan, Krishna ^b   Otten, Richard F ^b   Stafkey Mailey, Dana R ^b,c   Taylor, Stephanie D ^d   Erickson, Steven R ^d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Acute coronary syndrome; Adherence

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ADVERSE DRUG REACTION; AGED; BELIEFS ABOUT MEDICINE QUESTIONNAIRE; CLINICAL FEATURE; DEMOGRAPHY; FEMALE; HEALTH BEHAVIOR; HEART MUSCLE ISCHEMIA; HOSPITAL DISCHARGE; HUMAN; ILLNESS BEHAVIOR; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; REGRESSION ANALYSIS; REVIEW; SCORING SYSTEM; SELF REPORT; TELEPHONE; THINKING;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTILIPEMIC AGENTS; ASPIRIN; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; QUESTIONNAIRES; SYNDROME; TIME FACTORS; WITHHOLDING TREATMENT;

EID: 27344453717     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1G249     Document Type: Review

References (23)

1. American Heart Association. Heart disease and stroke statistics-2004 update. Dallas, TX: American Heart Association, 2003.
2. Mehta RH, Montoye CK, Gallogy M, Baker P, Blount A, Faul J, et al. GAP Steering Committee of the American College of Cardiology. Improving quality of care for acute myocardial infarction: the Guidelines Applied in Practice (GAP) Initiative. JAMA 2002;287:1269-76.
3. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002;288:462-7.
4. Cline CMJ, Björck-Cinné AK, Israelsson BYA, Willenheimer RB, Erhardt LR. Non-compliance and knowledge of prescribed medication in elderly patients with heart failure. Eur J Heart Fail 1999;1:145-9.
5. Dunbar-Jacob J, Bohachick P, Mortimer MK, Sereika SM, Foley SM. Medication adherence in persons with cardiovascular disease. J Cardiovasc Nurs 2003;18:209-18.
6. Gallagher EJ, Viscoli CM, Horwitz RI. The relationship of treatment adherence to the risk of death after myocardial infarction in women. JAMA 1993;270:742-4.
7. Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction, I: mortality results. JAMA 1982;247:1707-14.
8. Berg JS, Dischler J, Wagner DJ, Raia JJ, Palmer-Shevlin N. Patient compliance: a healthcare problem. Ann Pharmacother 1993;27(9 suppl):S5-19.
9. Horne R. Representations of medication and treatment: advances in theory and measurement. In: Petrie KJ, Weinman J, eds. Perceptions of health and illness: current research and applications. London: Harwood Academic, 1997:155-87.
10. Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining nonadherence to preventor medication. Psychol Health 2002;17:17-32.
11. Leventhal H. Cameron L. Behavioural theories and the problem of compliance. Patient Educ Counsel 1987;10:117-38.
12. Horne R, Weinman J, Hankins M. The Beliefs About Medicines Questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999;14:1-24.
13. Morisky DE, Green LW, Levine DM. Concurrent predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74.
14. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419-24.
15. Roe CM, Motheral BR, Teitelbaum F, Rich MW. Compliance with and dosing of angiotensin-converting-enzyme inhibitors before and after hospitalization. Am J Health Syst Pharm 2000;57:139-45.
16. Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ 1995;311:293-5.
17. Caro JJ. Stepped care for hypertension: are the assumptions valid? J Hypertens 1997;15(suppl):S35-9.
18. Simpson E, Beck C, Richard H, Eisenberg MJ, Pilote L. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence. Am Heart J 2003;145:438-44.
19. Andrade SE, Walker AM, Gottlieb LK, Hollenberg NK, Testa MA, Saperia GM, et al. Discontinuation of antihyperlipidemic drugs-do rates reported in clinical trials reflect rates in primary care settings? N Engl J Med 1995;332:1125-31.
20. Choo PW, Rand CS, Inui TS, Lee ML, Cain E, Cordeiro-Breault M, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999;37:846-57.
21. Vermeire E, Hearnshaw H, VanRoyen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 2001;26:331-42.
22. Burke LE, Dunbar-Jacob JM, Hill MN. Compliance with cardiovascular disease prevention strategies: a review of the research. Ann Behav Med 1997;19:239-63.
23. Krumholz HM, Amatruda J, Smith GL, Mattera JA, Roumanis SA. Randomized trial of an education and support intervention to prevent read-mission of patients with heart failure. J Am Coll Cardiol 2002;39:83-9.